3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
41
Carcinoma, Non-Small-Cell Lung
27
Colorectal Neoplasms
17
Neoplasms
13
Prostatic Neoplasms
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
10
Leukemia, Myeloid, Acute
9
Stomach Neoplasms
8
Small Cell Lung Carcinoma
8
Ovarian Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Esophageal Neoplasms
7
Triple Negative Breast Neoplasms
6
Pancreatic Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Recurrence
5
Glioblastoma
5
Esophageal Squamous Cell Carcinoma
5
Colonic Neoplasms
5
Carcinoma, Renal Cell
5
Brain Neoplasms
5
Adenocarcinoma
5
Urinary Bladder Neoplasms
4
Lymphoma, Follicular
4
Interventions
pembrolizumab
1
enfortumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
Advanced Bladder Cancer
×
Clear all
NCT07346053
2026-01-16
Chrono-EVP
British Columbia Cancer Agency
Phase 3
Not yet recruiting
224 enrolled